3,604
Participants
Start Date
October 31, 2007
Primary Completion Date
February 29, 2008
Study Completion Date
July 31, 2008
Cell culture-derived influenza subunit vaccine (cTIV)
One 0.5 ml injection of the cell culture-derived influenza vaccine in the deltoid muscle, preferably of the nondominant arm.
Egg derived influenza subunit vaccine (eTIV)
One 0.5 ml injection of the conventional egg-derived influenza vaccine in the deltoid muscle, preferably of the nondominant arm.
Cell culture-derived influenza subunit vaccine (cTIV)
Two 0.5 mL injections,of the cell culture-derived influenza vaccine in the deltoid muscle, preferably of the nondominant arm, administered four weeks apart.
Egg derived influenza subunit vaccine (eTIV)
Two 0.5 mL injections of the conventional egg-derived influenza vaccine in the deltoid muscle, preferably of the nondominant arm,administered four weeks apart.
Site 57: Házi Gyermekorvosi Rendelő, Budapest
Site 53: Heim Pál Gyermekkórház, Budapest
Site 52: Ferencvárosi Gyermekorvos Kft., Budapest
Site 56: Házi Gyermekorvosi Rendelő, Budapest
Site 54: Házi Gyermekorvosi Rendelő, Budapest
Site 51: 5053. számú Gyermekorvosi Rendelő, Miskolc
Site 55: Revamed kft., Nyíregyháza
Site 59: Vas Megyei Markusovszky Lajos, Általános, Rehabilitációs és Gyógyfürdő Kórház, Egyetemi Oktató Kórház, Szombathely
Site 31, Vilnius
Site 33, Vilnius
Site 05, Endwell
Site 67: Lahden rokotetutkimusklinikka, Lahti
Site 47: Dipartimento Scienze della Salute, Sezione di Igiene e Medicina Preventiva, Univesità di Genova, Genova
Site 69: Turun rokotetutkimusklinikka, Turku
Site 06, Burke
Site 41: Ospedale Maggiore della Carità-Clinica Pediatrica, Novara
Site 68: Porin rokotetutkimusklinikka, Pori
Site 66: Tampereen rokotetutkimusklinikka, Tampere
Site 02, Bardstown
Site 42: Dipartimento di Medicina Clinica e Sperimentale - Sezione di Igiene e Medicina Preventiva, Ferrara
Site 35, Kaunas
Site 77: Kotkan rokotetutkimusklinikka, Kotka
Site 01, St Louis
Site 79: Kokkola Vaccine Research Clinic, Rantakatu 7
Site 11, Omaha
Site 14, Metairie
Site 78: Kuopio Vaccine Research Clinic, Microkatu 1,Osa/Section A, 3rd Floor Pl1188
Site 09, Fayetteville
Site 16, Fort Worth
Site 13, San Angelo
Site 12, San Antonio
Site 08, Bountiful
Site 07, Salt Lake City
Site 03, Salt Lake City
Site 75: Oulun rokotetutkimusklinikka, Oulu
Site 10, Downey
Site 45: AUSL 7, Ragusa
Site 15, Spokane
Site 25, Campulung Muscel
Site 21, Craiova
Site 04, Edison
Site 27:Institute of Public Health, Zagreb
Site 29: Institute of Public Health, Zagreb
Site 40:Spec. Pediatric Dispensary, Zagreb
Site 49: Spec. Pediatric Dispensary, Zagreb
Site 50: Spec. Pediatric Dispensary, Zagreb
Site 86: Spec. Pediatric Dispensary, Zagreb
Site 44:Spec. Pediatric Dispensary, Đakovo
Site 43: Spec. Pediatric Dispensary, Sisak
Site 83, Ljudevita Gaja 2, Djakovo
Site 70: Espoon rokotetutkimusklinikka, Heikintori
Site 71: Etelä-Helsingin rokotetutkimusklinikka, Helsinki
Site 72: Itä-Helsingin rokotetutkimusklinikka, Helsinki
Site 76: Järvenpään rokotetutkimusklinikka, Järvenpää
Site 73: Itä-Vantaan rokotetutkimusklinikka, Vantaa
Site 74: Länsi-Vantaan rokotetutkimusklinikka, Vantaa
Site 46: USL 2 Perugia, Distretto del perugino, Centro di Salute n. 4 (Madonna Alta) e n. 6 (Ellera di Corciano del distretto del perugino), Perugia
Site 36, Vilnius
Site 32, Vilnius
Site 34, Vilnius
Lead Sponsor
Collaborators (1)
Novartis Vaccines
INDUSTRY
Novartis
INDUSTRY